These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9286645)

  • 21. Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?
    Izawa JI; Lega I; Downey D; Chin JL; Luke PP
    BJU Int; 2005 Aug; 96(3):320-3. PubMed ID: 16042722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in patterns of practice in diagnosing screen-detected prostate cancer.
    Nam RK; Toi A; Trachtenberg J; Jewett MA; Klotz L; Fleshner N; Bagnell PS; Sweet J; Sugar L; Narod SA
    BJU Int; 2004 Dec; 94(9):1239-44. PubMed ID: 15610097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluctuating prostate-specific antigen levels in patients with initial negative biopsy: should we be reassured?
    Celhay O; de la Taille A; Salomon L; Doré B; Irani J
    BJU Int; 2007 May; 99(5):1028-30. PubMed ID: 17324221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population.
    Gokden N; Roehl KA; Catalona WJ; Humphrey PA
    Urology; 2005 Mar; 65(3):538-42. PubMed ID: 15780372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
    Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
    Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of percent free prostate specific antigen as a predictor of prostate cancer detection on repeat biopsy.
    Uemura H; Nakamura M; Hasumi H; Sugiura S; Fujinami K; Miyoshi Y; Yao M; Kubota Y
    Int J Urol; 2004 Jul; 11(7):494-500. PubMed ID: 15242358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
    J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.
    Borboroglu PG; Sur RL; Roberts JL; Amling CL
    J Urol; 2001 Sep; 166(3):866-70. PubMed ID: 11490235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recutting prostate needle core biopsies with high grade prostatic intraepithelial neoplasia increases detection of adenocarcinoma.
    Rapp DE; Msezane LP; Reynolds WS; Lotan TL; Obara P; O'Connor RC; Taxy JB; Gerber GS; Zagaja GP
    Can J Urol; 2009 Feb; 16(1):4484-9. PubMed ID: 19222887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of prostatic intraepithelial neoplasia on blood levels of PSA and free PSA percentage].
    Morote J; López M; de Torres IM; de Torres JA
    Actas Urol Esp; 1999 Apr; 23(4):342-9. PubMed ID: 10394655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract.
    Häggman MJ; Adolfsson J; Khoury S; Montie JE; Norlén J
    Scand J Urol Nephrol Suppl; 2000; (205):44-9. PubMed ID: 11144903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy.
    Park S; Shinohara K; Grossfeld GD; Carroll PR
    J Urol; 2001 May; 165(5):1409-14. PubMed ID: 11342887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
    Epstein JI; Herawi M
    J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma.
    Netto GJ; Epstein JI
    Am J Surg Pathol; 2006 Sep; 30(9):1184-8. PubMed ID: 16931964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).
    Roobol MJ; van der Cruijsen IW; Schröder FH
    Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.
    Djavan B; Fong YK; Ravery V; Remzi M; Horninger W; Susani M; Kreuzer S; Boccon-Gibod L; Bartsch G; Marberger M
    Eur Urol; 2005 Jan; 47(1):38-44; discussion 44. PubMed ID: 15582247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
    Stewart J; Fleshner N; Cole H; Toi A; Sweet J
    J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.